<bill session="111" type="h" number="6389" updated="2023-01-11T13:21:29Z">
  <state datetime="2010-09-29">REFERRED</state>
  <status>
    <introduced datetime="2010-09-29"/>
  </status>
  <introduced datetime="2010-09-29"/>
  <titles>
    <title type="display">Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010</title>
    <title type="official" as="introduced">To reduce disparities and improve access to effective and cost efficient diagnosis and treatment of prostate cancer through advances in testing, research, and education, including through telehealth, comparative effectiveness research, and identification of best practices in patient education and outreach particularly with respect to underserved racial, ethnic and rural populations and men with a family history of prostate cancer, to establish a directive on what constitutes clinically appropriate prostate cancer imaging, and to create a prostate cancer scientific advisory board for the Office of the Chief Scientist at the Food and Drug Administration to accelerate real-time sharing of the latest research and accelerate movement of new medicines to patients.</title>
    <title type="short" as="introduced">PROSTATE Act</title>
    <title type="short" as="introduced">Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010</title>
  </titles>
  <sponsor bioguide_id="T000326"/>
  <cosponsors/>
  <actions>
    <action datetime="2010-09-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2010-09-29" state="REFERRED">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2010-09-29">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2010-09-29">
      <text>Referred to House Armed Services</text>
    </action>
    <action datetime="2010-09-29">
      <text>Referred to House Veterans' Affairs</text>
    </action>
    <action datetime="2010-10-20">
      <text>Referred to the Subcommittee on Military Personnel.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSAS" name="House Armed Services" subcommittee="" activity="Referral"/>
    <committee code="HSAS02" name="House Armed Services" subcommittee="Military Personnel" activity="Referral"/>
    <committee code="HSVR" name="House Veterans' Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="111" type="s" number="3775" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Cancer"/>
    <term name="Executive agency funding and structure"/>
    <term name="Government information and archives"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Minority health"/>
    <term name="Research administration and funding"/>
    <term name="Sex and reproductive health"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2011-02-22T21:40:39Z" status="Introduced in House">Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010 or the PROSTATE Act - Requires the Secretary of Veterans Affairs (VA) to establish the Interagency Prostate Cancer Coordination and Education Task Force, which shall: (1) develop a summary of advances in federal prostate cancer research and compile a list of best practices for treatment of prostate cancer that warrant broader adoption in health care programs; (2) consider establishing guidance to enable physicians to allow screening of men over age 74; (3) coordinate information on federal research and health care program activities relating to prostate cancer; (4) develop a comprehensive interagency strategy on, and advise agencies in, the solicitation of proposals for collaborative, multidisciplinary research and health care programs relating to prostate cancer; (5) develop a coordinated message related to screening and treatment for prostate cancer to be reflected in educational and beneficiary materials for federal health programs; and (6) submit recommendations regarding federal research and health care programs.

Directs the Secretary to establish and carry out a program to coordinate and intensify prostate cancer research, including by establishing clinical registries for prostate cancer and awarding research grants.

Establishes in the Office of the Chief Scientist of the Food and Drug Administration (FDA) a Prostate Cancer Scientific Advisory Board to be responsible for accelerating real-time sharing of the latest research data and accelerating movement of new medicines to patients.

Directs the Secretary to: (1) establish four-year telehealth pilot projects for the purpose of analyzing the clinical outcomes and cost effectiveness associated with telehealth services in a variety of geographic areas that contain high proportions of medically underserved populations and those in rural areas; and (2) develop a national education campaign for prostate cancer.</summary>
</bill>
